A cross-sectional study assessing adverse events in patients with chronic migraine receiving onabotulinum toxin A according to the PREEMPT protocol
Latest Information Update: 27 Sep 2016
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Migraine
- Focus Adverse reactions
- 27 Sep 2016 New trial record